C2U-13475-73169
4 vaccinations
9 coded responses
25 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 212 / MD
- Registered
- 2021-11-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
XCS-11003-80248
Child or adolescent in my care · Male · 2021-11-08
3KL-19856-98879
Child or adolescent in my care · Male · 2022-06-23
Timeline
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-02-04
Dose 2 — Pfizer-BioNTech
-
2021-11-08
Registered in v-safe
-
2021-11-29
Dose 3 — Pfizer-BioNTech
-
2021-11-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-02
- 2021-12-03
-
2021-12-04
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Fair · Site: PainFree text: Swelling under arm where I got the shotMedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Good · Site: PainFree text: Under arm swelling on arm where I got the shotMedDRA releases: 2024-11 · check-in free text available
-
2021-12-09
Survey response — day 7, dose 3MedDRA: Oedema peripheral — Feeling: GoodFree text: Under arm swellingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-13
-
2021-12-21
Survey response — day 21, dose 3MedDRA: Nasal pruritus, Pruritus — Feeling: FairFree text: Itchy nose and faceMedDRA releases: 2024-11 · check-in free text available
- 2022-01-03
-
2022-01-10
Survey response — day 42, dose 3MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend schoolFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-03-01
- 2022-05-30
-
2022-11-02
Dose 4 — Pfizer-BioNTech
-
2022-11-02
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-11-03
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-11-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2022-11-05
- 2022-11-06
-
2022-11-07
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Swelling · Fatigue or tirednessAdult check-in
- 2022-11-11
-
2022-11-23
Survey response — day 21, dose 4MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Sore throat, nasal congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-30
Survey response — day 28, dose 4MedDRA: Dizziness, Eye pain, Headache, Nasal congestion, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend schoolFree text: Nasal congestion, sore throat, dizziness, headache, eye painMedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Survey response — day 35, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2023-02-01
Survey response — 3 months, dose 4MedDRA: Amenorrhoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-01
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-02-02
Call successfulCompleted over the phone
- 2023-05-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | No |
| 2 | 2021-02-04 | Pfizer-BioNTech | No |
| 3 | 2021-11-29 | Pfizer-BioNTech | No |
| 4 | 2022-11-02 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swelling under arm where I got the shot
Systemic reaction (other): Under arm swelling on arm where I got the shot
Release 10 — day 7, dose 3
Systemic reaction (other): Under arm swelling
Release 10 — day 21, dose 3
Symptoms: Itchy nose and face
Release 10 — day 42, dose 3
Symptoms: Cold symptoms
Release 12 — day 21, dose 4
Symptoms: Sore throat, nasal congestion
Release 12 — day 28, dose 4
Symptoms: Nasal congestion, sore throat, dizziness, headache, eye pain
Release 12 — day 35, dose 4
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Amenorrhoea | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Eye pain | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasal pruritus | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release